Merck & Co., Inc. is 143.2x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($294.13 B vs $2.05 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HRMY | MRK |
|---|---|---|
| Market cap | $2.05 B | $294.13 B |
| US-listed rank | #2085 | #44 |
| Revenue (latest FY) | $868.45M | $65.01B |
| Net income (latest FY) | $158.69M | $18.25B |
| Net margin | 18.3% | 28.1% |
| P/E (trailing FY) | 12.9 | 16.1 |
| SEC filings | 434 | 996 |
Merck & Co., Inc. is 143.2x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($294.13 B vs $2.05 B).
In their latest fiscal years, Harmony Biosciences Holdings, Inc. reported $868.45M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Harmony Biosciences Holdings, Inc. and Merck & Co., Inc., or browse the full rankings.